Strategic Imperatives - University of Houston
Skip to main content

College of Pharmacy

Strategic Imperatives

  • 1. Secure a physical location in the TMC and maintain a footprint in the TMC (Goal 2: Nationally Competitive Research)

    1. Have laboratory space
    2. Have a dedicated classroom space in the TMC for PLA, Advanced Pharmacy Practice Experiences (APPEs) and Interprofessional Education (IPE) programs as well as study area for APPE students
    3. Have office space in the TMC for experiential and other faculty

  • 2. Establish research infrastructure, administration, training and resources to facilitate collaboration between UH and RGV, especially in the area of health disparities research (Goal 2: Nationally Competitive Research)

    1. Maintain established standard research agreements between UHCOP main campus DHR Health Institute for Research and Development (DHRIRD) every 5 years
    2. Have a minimum of 2 collaborative UHCOP-DHIRD research projects pursuing funding in progress by 2025 then determine increase for 2030 to meet funding goal. Among the projects, at least one collaborative research project should involve research with the unique RGV population or use the existing data base to address the health-disparity issue or include investigators from UHCOP-RGV
    3. Obtain $250K in joint, externally funded research projects by 2025 and $1M by 2030
    4. Have a minimum of 2 joint publications per year and/or RGV authors by 2025 then determine minimum number per year for time period 2025-2030
    5. RGV faculty will complete at least 2 research-related trainings by 2023

  • 3. Focus and strengthen the college’s research infrastructure, administration and areas of research expertise (Goal 2: Nationally Competitive Research)

    1. Increase Center Grants (P01, P50, P20, U54)
    2. Strengthen research expertise
    3. Strengthen and expand infrastructure
    4. Increase training grants (R25, T32, T35)
    5. Strengthen training grant support infrastructure
    6. Increase Multi-Principal Investigator grants (R01)
    7. Form or enhance two strategic partnerships

  • 4. Enhance Innovation in the delivery of pharmacy education (Goal 1: Student Success)

    1. Establish a taskforce by summer 2022 to create an infrastructure to develop and integrate innovative teaching and SoTL and methods into the Pharm.D. Curriculum
    2. Establish a baseline number of SoTL publications and presentations by fall 2023 and then increase by 25% by 2032
    3. Continue incorporating evidence-based practices for SoTL research to continuously improve teaching as measured by curricular outcomes
    4. Establish a quarterly lecture series by fall 2023 to address best practices and overcoming obstacles to SoTL success

  • 5. Continued advocacy for funding considerations at the university and state level (Goal 5: Competitive Funding)

  • 6. Improve/maintain National Quality Metrics (Goal 1: Student Success)

    1. Maintain our top 10% ranking in NAPLEX scores nationally
    2. Increase research expenditures by at least 50% by 2032 ($5M)
    3. Increase the productivity (number of publications, impact factor of journal and faculty H factor) through peer reviewed publications by 25%
    4. Increase quantity of Ph.D. graduates by 25% by 2030
    5. Increase the quality of Ph.D. graduates

  • 7. Provide facility and innovative technological resources for students, faculty and staff necessary to meet the extensive goals of a Tier 1 Pharmacy College (Goal 1: Student Success)

    1. Secure additional space for research and growing centers by 2032
    2. Expand state of the art research facilities to increase federal funding and top-tier journal publications 50% by 2032
    3. Build and infrastructure of IT resources to improve teaching and research outcomes, as measured by student success and research productivity, by 2032
    4. By 2032, establish an environment that is resilient against internal and external disruption to educational and research activity